SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-001154
Filing Date
2020-04-13
Accepted
2020-04-13 16:06:21
Documents
34
Period of Report
2020-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannabics_10q-022920.htm 10-Q 376886
2 CERTIFICATION cannabics_ex3101.htm EX-31.1 11065
3 CERTIFICATION cannabics_ex3102.htm EX-31.2 11069
4 CERTIFICATION cannabics_ex3201.htm EX-32.1 5421
5 CERTIFICATION cannabics_ex3202.htm EX-32.2 5235
6 GRAPHIC image_002.jpg GRAPHIC 4636
7 GRAPHIC image_003.jpg GRAPHIC 5139
  Complete submission text file 0001683168-20-001154.txt   1213560

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE cnbx-20200229.xml EX-101.INS 97910
9 XBRL SCHEMA FILE cnbx-20200229.xsd EX-101.SCH 11954
10 XBRL CALCULATION FILE cnbx-20200229_cal.xml EX-101.CAL 27510
11 XBRL DEFINITION FILE cnbx-20200229_def.xml EX-101.DEF 20293
12 XBRL LABEL FILE cnbx-20200229_lab.xml EX-101.LAB 101972
13 XBRL PRESENTATION FILE cnbx-20200229_pre.xml EX-101.PRE 74312
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 20788870
SIC: 2834 Pharmaceutical Preparations